✦ LIBER ✦

Clinical experience with perindopril, an angiotensin converting enzyme inhibitor (ACEI), in U.S. hypertensive patients - a large community-based trial

✍ Scribed by Stevo Julius; Michael Weber; Joel Neutel; Jay N. Cohn; Weinong Guo; Alicia Batchelor; Yannan Shen; Victor Dong; Hjalmar Lagast; Prasad Turlapaty

Book ID: 117601715
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 40 KB
Volume: 16
Category: Article
ISSN: 0895-7061
DOI: 10.1016/s0895-7061(03)00116-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical experience with perindopril in

Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial

✍ Jay N Cohn; Stevo Julius; Joel Neutel; Michael Weber; Prasad Turlapaty; Yannan S 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 71 KB

Effect of perindopril erbumine, an angio

Effect of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), on blood pressure in patients with mild to moderate hypertension - a large Aceon® Community Trial (ACT) with 8083 patients

✍ Michael Weber; Alicia Pohorille; Prasad Turlapaty 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 41 KB

Efficacy and safety of perindopril erbum

Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 2269 elderly hypertensive patients: subgroup analysis of a 12-week, open-label, Aceon® Community Trial (ACT)

✍ Joel Neutel; Alicia Pohorille; Fred Carter 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 41 KB

Efficacy and safety of perindopril erbum

Efficacy and safety of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in 899 hypertensive patients on oral hypoglycemic agents - subgroup analysis of a 12-week, open-label, aceon® Community Trial (ACT)

✍ Jay N. Cohn; Alicia Pohorille; David Golod 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 39 KB

Effect of perindopril erbumine, an angio

Effect of perindopril erbumine, an angiotensin converting enzyme inhibitor (ACE-I), in the treatment of 1022 African-American patients with mild to moderate hypertension: subgroup analysis of a 12 week, open-label, Aceon®Community Trial (ACT)

✍ Stevo Julius; Alicia Pohorille; Staci Rokette 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 49 KB

Renal Outcomes in High-Risk Hypertensive

Renal Outcomes in High-Risk Hypertensive Patients Treated With an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Blocker vs. a Diuretic. A Report From the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

✍ M. Rahman; S. Pressel; B.R. Davis 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 40 KB